Evidence for low risk of Clostridium difficile infection associated with tigecycline
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference25 articles.
1. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9‐t‐butylglycylamido derivative of minocycline (GAR‐936);Petersen;Antimicrob Agents Chemother,1999
2. In vitro susceptibility of anaerobic bacteria to GAR‐936, a new glycylcycline;Edlund;Clin Microbiol Infect,2000
3. Effect of tigecycline on normal oropharyngeal and intestinal microflora;Nord;Antimicrob Agents Chemother,2006
4. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model;Baines;J Antimicrob Chemother,2005
5. Comparison of the efficacy of ramoplanin vs vancomycin in both in vitro and in vivo models of clindamycin‐induced Clostridium difficile infection;Freeman;J Antimicrob Chemother,2005
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence;Annals of Pharmacotherapy;2022-06-03
2. Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?;BMC Infectious Diseases;2016-04-18
3. Tigecycline exhibits inhibitory activity against Clostridium difficile in the intestinal tract of hospitalised patients;International Journal of Antimicrobial Agents;2015-04
4. Infections in the Immunocompromised Host;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015
5. Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection;Infectious Diseases and Therapy;2014-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3